Rekombinanter LAG3 Antikörper
Kurzübersicht für Rekombinanter LAG3 Antikörper (ABIN7543409)
Target
Alle LAG3 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-LAG-3 [22G3], Mouse IgG2a, kappa
-
Spezifität
- The antibody is specific for LAG3. Lymphocyte activation gene 3 protein is an inhibitory receptor on antigen activated T-cells. It delivers inhibitory signals upon binding to ligands, such as FGL1.
-
Produktmerkmale
-
Original Species of Ab: Mouse
Original Format of Ab: IgG2a
-
Aufreinigung
- Protein A affinity purified
-
Immunogen
- The original antibody was generated by immunizing mice with recombinant LAG3 protein.
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- The antibody specifically detected LAG3 protein in Western blot analysis. The antibody and the commercial antibody EPR20261 were used to stain tonsillar granulocytes and granulocytes in the appendix. Results showed the antibody specificity is comparable to the commercial antibody. Further, the sensitivity of the antibody 22G3 was higher than the commercial antibody. The antibody and the commercially available antibody E3 were simultaneously detected on the normal tissue chip, indicating that the specificity of the antibody in normal tissue was equivalent to that of the commercially available antibody (CN113234159A).
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Andere Bezeichnung
- LAG-3
-
Hintergrund
- CD223, LAG3, Lymphocyte-activation gene-3, Lymphocyte activation gene 3 protein, LAG-3, CGMCNO 20774
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-